Navigation Links
Helix BioPharma Provides Updates on Topical Interferon Alpha-2b and L-DOS47 Following Pre-IND Meetings With the U.S. FDA
Date:10/6/2009

n Germany. The pharmacokinetic trial will enroll up to 28 patients in order to obtain a minimum of 12 patients for evaluation for the primary study endpoint. Helix plans to proceed with filing its Phase II/III IND if sufficient positive data are obtained from the first 12 patients completing the study, and all other study findings are positive. If required, Helix may expand the data set beyond the first 12 patients if the results indicate more data are needed. Preliminary findings from patients enrolled so far in this study show no significant systemic interferon alpha-2b exposure. While the study is progressing, enrollment to date has been slower than previously anticipated. Given the recruiting challenges to date, the Company has revised its timeline for the pharmacokinetic study. In order to enhance the patient recruitment rate, the Company intends to open additional clinical sites during the Company's second quarter of fiscal 2010. Assuming the patient recruitment rate improves as planned, Helix now expects it will take until the end of its third quarter of fiscal 2010 for the 12 minimum required patients to complete the study, and up to the end of its first quarter of fiscal 2011 for all 28 patients to do so.

Helix has also confirmed that it must successfully complete its ongoing, scale-up, GMP engineering batch manufacturing and preliminary stability testing program before filing its U.S. Phase II/III IND.

Given the anticipated timeline for the pharmacokinetic study activities, and assuming successful completion of the scale-up GMP engineering batch manufacturing, Helix now projects that its U.S. Phase II/III IND filing will occur, at the earliest, in its fourth quarter of fiscal 2010. This revised timeline is subject to the successful and timely completion of these activities and assumes that no events occur which could cause further delay.

As part of the pre-IND meeting, Helix has also confirmed its previously
'/>"/>

SOURCE Helix BioPharma Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Helix Receives Approval to Open Sites in Germany for its Ongoing Clinical Trial With Topical Interferon Alpha-2b in Patients With Ano-Genital Warts
2. J. Craig Venter, Ph.D. Receives Double Helix Medal from Cold Spring Harbor Laboratory
3. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
4. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
5. Nabi Biopharmaceuticals Announces Continued Positive NicVAX Phase 2b Data at Nine Months
6. Keryx Biopharmaceuticals to Present at William Blair & Company Small-Cap Growth Stock Conference
7. Morria Biopharmaceuticals Plc Initiates Phase I Clinical Study of MRX-4 in Allergic Rhinitis
8. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma
9. Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months
10. Inspiration Biopharmaceuticals Announces Filing of IND for Novel Recombinant Factor IX Product, IB1001, for the Treatment of Hemophilia B
11. Immunosyn Announces Biozyme Labs Receipt of MHRA Manufacturing License Approval in Europe for the Biopharmaceutical SF-1019
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... MARLTON, N.J. , July 25, 2014 /PRNewswire/ ... visibility, brand protection and serialization solutions, has recently ... Business" that addresses current and future needs ... solutions for the old supply chain model no ... advances in technology, including the growth of mobile ...
(Date:7/25/2014)... New York , July 25, 2014 ... by Transparency Market Research "Global and China Insulin Market ... - Industry Analysis, Size, Share, Growth, Trends and Forecast ... market was valued at USD 19.99 billion in 2012 ... 6.1% from 2013 to 2019 to reach USD 32.24 ...
(Date:7/25/2014)... 25, 2014 Research and Markets ... Diagnostic Devices Market 2014-2018" report to their offering. ... About Ophthalmic Diagnostic Device An ophthalmic ... a defect or deficiency in the human visual pathway. ... such as presbyopia, cataracts, glaucoma, retinal disorders, conjunctivitis, and ...
Breaking Medicine Technology:Acsis Addresses Questions on the Modern Supply Chain 2Global Insulin Market Expected to Reach USD 32.24 Billion Globally in 2019: Transparency Market Research 2Global Insulin Market Expected to Reach USD 32.24 Billion Globally in 2019: Transparency Market Research 3Global Insulin Market Expected to Reach USD 32.24 Billion Globally in 2019: Transparency Market Research 4Global Ophthalmic Diagnostic Devices Market 2014-2018: Key Vendors are Alcon, Carl Zeiss, Haag-Streit and Topcon 2
(Date:7/25/2014)... According to a new market ... (vibration monitoring, thermography, ultrasound emission, lubricating oil analysis, ... and Geography - Global Forecast to 2014 - ... market is expected to reach $2.50 at a ... Browse 117 market data Tables and 57 Figures ...
(Date:7/25/2014)... 2014 Ticket Down announces ... for the Guinness International Champions Cup match between international ... Soldier Field on Sunday, July 27th. This ... promo/coupon/offer code SOCCER-2014 for added savings. , 2014 is ... soccer fans in North America. Countless international soccer teams ...
(Date:7/25/2014)... 2014 As reported by Wood TV 8 ... (7/20), Michigan has seen a nearly 500-person increase in heroin ... count was 271 between 1999 and 2002, the toll increased ... that, like other states, drug users in Michigan have turned ... pills. He compared the price of both substances, noting that ...
(Date:7/25/2014)... The human brain can preserve oxygen to protect itself ... Although dehydration significantly reduces blood flow to ... brain compensates by increasing the amount of oxygen it ... us understand a lot more about how the human ... first author Steven Trangmar, a researcher at Brunel University, ...
(Date:7/25/2014)... Ticket Down is a reliable source for ... at California Memorial Stadium. With the post-World Cup emotions ... organizers of the 2014 Guinness International Champions Cup have brought ... With teams representing La Liga, English Premier League, Serie A, ... best football players from around the world to 12 American ...
Breaking Medicine News(10 mins):Health News:Machine Health Monitoring Market by Product, Component & Application Worth $2.50 Billion by 2020 - New Report by MarketsandMarkets 2Health News:Machine Health Monitoring Market by Product, Component & Application Worth $2.50 Billion by 2020 - New Report by MarketsandMarkets 3Health News:Machine Health Monitoring Market by Product, Component & Application Worth $2.50 Billion by 2020 - New Report by MarketsandMarkets 4Health News:Liverpool FC vs. Olympiacos FC Tickets Soldier Field: Ticket Down Slashes Ticket Prices for Guinness International Champions Cup in Chicago on Sunday, July 27th 2Health News:Rise in Heroin Use, Overdose Deaths in Michigan 2Health News:Human Brain Has Coping Mechanism for Dehydration 2Health News:Real Madrid vs. Inter Milan Tickets Berkeley: Ticket Down Slashes Ticket Prices on Guinness International Champions Cup Tickets at California Memorial Stadium 2Health News:Real Madrid vs. Inter Milan Tickets Berkeley: Ticket Down Slashes Ticket Prices on Guinness International Champions Cup Tickets at California Memorial Stadium 3
... could be coming to a pharmacy near you, thanks to ... and M.D. Anderson Cancer Center Orlando researchers. UCF,s ... Jimmie Colon teamed up about 18 months ago with a ... test to screen for prostate cancer that would be easy ...
... AustraliaJune 3, 2009A new review published in the Journal ... in diet have a beneficial effect on the prevention of ... and red meat and high in fruits and vegetables is ... W.-L. Ma and K. Chapman conducted an evidence-based review of ...
... medical-surgical market leaders across 35 product categories and five ... GHX today announced the ... recognizing 30 medical-surgical manufacturers that have achieved significant market ... 2008. Awards were given to companies that achieved the ...
... stage of growth and innovation at Click4Care , , ... care management software suite, today announced the appointment of Rob ... company through the next phase of its development, following its ... In addition to leading Click4Care, Gillette will continue as CEO ...
... : The National Infertility Association honored Reproductive Medicine Associates ... with The 2009 Friends of RESOLVE Award at their Annual Night ... program recognizes individuals and practices who have been devoted to assisting ... RESOLVE in helping the 7.3 million people in the U.S. build ...
... , Companies provide an unparalleled claim processing, benefit ... , , BURLINGTON, Mass., June 3 ... platform for healthcare payors, today announced that Rob ... HealthEdge, has also been named CEO of Ohio-based ...
Cached Medicine News:Health News:Effective over-the-counter prostate cancer test kit likely in next few years 2Health News:GHX Announces 2009 Best In Class Award Winners 2Health News:GHX Announces 2009 Best In Class Award Winners 3Health News:GHX Announces 2009 Best In Class Award Winners 4Health News:Click4Care(R) Announces Appointment of Rob Gillette as CEO 2Health News:National Infertility Organization Honors RMA of New York for Community Support 2Health News:HealthEdge(R) and Click4Care(R) Announce Common Leadership 2
... MicroAire® Hi Speed Pulse Lavage is ... surfaces as well as cleansing trauma ... a great system just got better ... with the addition of attachable ...
... a complete system of surgical instruments and ... fusion surgery. The system was designed in ... research and engineering with advanced materials, techniques ... different, and because the anatomy of the ...
... Addressing the key clinical and economic issues ... System is designed to maximize tension control ... The system combines efficient instrumentation with a ... Grip system is indicated for general orthopaedic ...
... Minimally Invasive Hip Instruments are ... through a mini-incision using a ... of instruments helps reduce the ... THA by optimizing exposure and ...
Medicine Products: